Thalidomide in Treating Patients With HIV-Associated Kaposi's Sarcoma
Status:
Completed
Trial end date:
2004-04-01
Target enrollment:
Participant gender:
Summary
RATIONALE: Thalidomide may kill cancer cells by stopping the growth of new blood vessels to
the tumor.
PURPOSE: Phase II trial to study the effectiveness of thalidomide in treating patients with
HIV-associated Kaposi's sarcoma.